Publication date: February 2018
Source:Journal of Allergy and Clinical Immunology, Volume 141, Issue 2
Author(s): Etienne C.E. Wang, Zhenpeng Dai, Angela M. Christiano
Treatments for alopecia areata (AA) have evolved over the decades from broad and nonspecific therapies to those that are now more targeted and rationally selected. This was achieved by means of close cooperation and communication between clinicians and basic scientists, which resulted in the elucidation and understanding of the unique pathophysiology of AA. In this review we discuss this evolution and how novel therapies for AA have changed over the decades, what we have in our current arsenal of drugs for this potentially devastating disease, and what the future holds.
http://ift.tt/2nN5Cj3
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου